 | Up a level |
Leoncini, Pier Paolo; Vitullo, Patrizia; Reddel, Sofia; Tocco, Valeria; Paganelli, Valeria; Stocchi, Francesca; Mariggiò, Elena; Massa, Michele; Nigita, Giovanni; Veneziano, Dario; Fadda, Paolo; Scarpa, Mario; Pigazzi, Martina; Bertaina, Alice; Rota, Rossella; Pagliara, Daria; Merli, Pietro (2022). MicroRNA profiling of paediatric AML with FLT-ITD or MLL-rearrangements: Expression signatures and in vitro modulation of miR-221-3p and miR-222-3p with BRD4/HATs inhibitors. Oncology reports, 48(6) National Hellenic Research Foundation 10.3892/or.2022.8436
Sartori, Elsa; Langer, Rupert; Vassella, Erik; Hewer, Ekkehard; Schucht, Philippe; Zlobec, Inti; Berezowska, Sabina Anna (2017). Low co-expression of epidermal growth factor receptor and its chaperone heat shock protein 90 is associated with worse prognosis in primary glioblastoma, IDH-wild-type. Oncology reports, 38(4), pp. 2394-2400. Spandidos Publications 10.3892/or.2017.5863
Vicinus, Benjamin; Rubie, Claudia; Stegmaier, Nathalie; Frick, Vilma Oliveira; Kölsch, Kathrin; Kauffels, Anne; Ghadjar, Pirus; Wagner, Mathias; Glanemann, Matthias (2013). miR-21 and its target gene CCL20 are both highly overexpressed in the microenvironment of colorectal tumors: significance of their regulation. Oncology reports, 30(3), pp. 1285-1292. Spandidos Publications 10.3892/or.2013.2580
Schraml, Peter; von Teichman, Adriana; Mihic-Probst, Daniela; Simcock, Mathew; Ochsenbein, Adrian; Dummer, Reinhard; Michielin, Olivier; Seifert, Bettina; Schläppi, Marc; Moch, Holger; von Moos, Roger (2012). Predictive value of the MGMT promoter methylation status in metastatic melanoma patients receiving first-line temozolomide plus bevacizumab in the trial SAKK 50/07. Oncology reports, 28(2), pp. 654-8. Athens: National Hellenic Research Foundation 10.3892/or.2012.1826
